Last reviewed · How we verify
NCT05433779: IMPROVE-2
Evaluation of Intravascular Monitoring of Partial PRessure of Oxygen for Neonatal intensiVE Care Patients -2
NA trial testing Neosense Umbilical Catheter in Catheter in 8 participants. Terminated before completion.
16 June 2023
Quick facts
| Lead sponsor | Neosense Technologies |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 8 |
| Start date | 15 December 2022 |
| Primary completion | 16 June 2023 |
| Estimated completion | 16 June 2023 |
| Sites | 5 locations across Sweden |
Drugs / interventions tested
- Neosense Umbilical Catheter
Conditions studied
- Catheter — all drugs for Catheter →
- Newborn, Infant, Disease — all drugs for Newborn, Infant, Disease →
- Lung Diseases — all drugs for Lung Diseases →
Sponsor
Neosense Technologies
Who can join
Eligibility, any sex, with Catheter or Newborn, Infant, Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study is a non-blinded trial with one single intervention in sick newborn infants. The Neosense umbilical catheter will be used instead of the routinely used umbilical catheter on infants where the treating physician has ordered use of an umbilical catheter. The catheter will be connected to the Neosense monitor/measuring unit. Blood samples for blood gas analysis are collected from the patients according to the clinical routine (every 4th to 6th hour). Oxygen tension data from the Neosense measuring system, from the time points when a blood gas sample was collected, will be recorded. This data will be compared to the oxygen tension value from the blood gas sample collected at the same time point. The blood gas samples will be analysed according to clinical and laboratory routine. The infants will remain in the study as long as the Neosense measuring system is used
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05433779
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Neosense Umbilical Catheter
Trials testing the same drug.
- NCT03967587 — Evaluation of Intravascular Monitoring of Partial PRessure of Oxygen for Neonatal intensiVE Care Patients · NA · terminated
Other Neosense Technologies trials
Trials by the same sponsor.
- NCT06616012 — Evaluation of Intravascular Monitoring of Partial PRessure of Oxygen for Neonatal IntensiVE Care Patients -3 · NA · enrolling by invitation
- NCT03967587 — Evaluation of Intravascular Monitoring of Partial PRessure of Oxygen for Neonatal intensiVE Care Patients · NA · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05433779 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Neosense Technologies
- Last refreshed: 21 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05433779.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing